Lixisenatide versus exenatide on metabolic control, insulin secretion and insulin sensitivity in patients with impaired glucose tolerance

Lixisenatide versus exenatide on metabolic control, insulin secretion and insulin sensitivity in patients with impaired glucose tolerance

Karina G. Pérez-Rubio 1, Esperanza Martínez-Abundis 1, Manuel González-Ortiz 1

1 Institute of Experimental and Clinical Therapeutics, Department of Physiology, Health Sciences University Center, University of Guadalajara, Guadalajara, Jal., Mexico

Karina G. Pérez-Rubio, Esperanza Martínez-Abundis, Manuel González-Ortiz

La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.

*Correspondence: Esperanza Martínez-Abundis, Email not available

Summary

Keywords:  Exenatide. Impaired glucose tolerance. Insulin secretion. Insulin sensitivity. Lixisenatide. Metabolic control.

Contents

DOI not available
Add to Mendeley
    Descargar PDF
    English versión
    DOI not available